Profusa (PFSA) Share-based Compensation (2022 - 2026)
Profusa's (PFSA) quarterly Share-based Compensation came in at $187000.0 in Q1 2026, up 3640.0% year-on-year from $5000.0 in Q1 2025, and up 150.0% quarter-over-quarter from -$374000.0 in Q4 2025.
Profusa (PFSA) Share-based Compensation (2022 - 2026) Analysis & Trends
Profusa's Share-based Compensation history runs 5 years deep, the most recent figure standing at $187000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 3640.0% year-over-year to $187000.0 in Q1 2026; TTM through Mar 2026 was $435000.0, a 64.74% increase from a year earlier, with the FY2025 full-year figure at $330000.0, up 1471.43% from the prior year.
- Share-based Compensation climbed to $187000.0 in Q1 2026 per PFSA's latest filing, from -$374000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.3 million in Q1 2023 and bottomed at -$374000.0 in Q4 2025.
- The 5-year median for Share-based Compensation is $214523.5 (2023), against an average of $341067.5.
- Biggest YoY gain for Share-based Compensation was 5041.67% in 2025; the steepest drop was 7580.0% in 2025.
- Year by year, Share-based Compensation stood at $1.0 million in 2022, then tumbled by 76.21% to $242047.0 in 2023, then sank by 97.93% to $5000.0 in 2024, then tumbled by 7580.0% to -$374000.0 in 2025, then jumped by 150.0% to $187000.0 in 2026.
- Per Business Quant, the three latest PFSA Share-based Compensation figures stand at $187000.0 (Q1 2026), -$374000.0 (Q4 2025), and $617000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | 187,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,000.00 |
| Mar 31, 2026 | 187,000.00 |
| Dec 31, 2025 | -374,000.00 |
| Dec 31, 2025 | -374,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2023 | 242,047.00 |
| Sep 30, 2023 | 242,047.00 |
| Jun 30, 2023 | 419,670.00 |
| Jun 30, 2023 | 419,670.00 |
| Mar 31, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Sep 30, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.02 Mn |